Arvinas Inc
Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company develops proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. It is also developing… Read more
Arvinas Inc (ARVN) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: -0.070x
Based on the latest financial reports, Arvinas Inc (ARVN) has a cash flow conversion efficiency ratio of -0.070x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-30.40 Million) by net assets ($433.90 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Arvinas Inc - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Arvinas Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Arvinas Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Arvinas Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Carasso Real Estate Ltd
TA:CRSR
|
-0.055x |
|
Shandong Mining Machinery Group Co Ltd
SHE:002526
|
0.049x |
|
Hnac Technology Co Ltd
SHE:300490
|
0.023x |
|
Beijing Zhidemai Technology
SHE:300785
|
-0.021x |
|
Olav Thon Eiendomsselskap ASA
LSE:0FHP
|
0.021x |
|
Sumitomo Osaka Cement Co. Ltd
F:SU2
|
N/A |
|
Heineken Bhd
KLSE:3255
|
0.327x |
|
Zhejiang Construction Investment Group Co Ltd
SHE:002761
|
0.044x |
Annual Cash Flow Conversion Efficiency for Arvinas Inc (2016–2025)
The table below shows the annual cash flow conversion efficiency of Arvinas Inc from 2016 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $433.90 Million | $-273.80 Million | -0.631x | -36.69% |
| 2024-12-31 | $561.70 Million | $-259.30 Million | -0.462x | +12.40% |
| 2023-12-31 | $660.00 Million | $-347.80 Million | -0.527x | -8.84% |
| 2022-12-31 | $564.90 Million | $-273.50 Million | -0.484x | -167.66% |
| 2021-12-31 | $781.70 Million | $559.40 Million | 0.716x | +612.02% |
| 2020-12-31 | $642.20 Million | $-89.76 Million | -0.140x | +22.01% |
| 2019-12-31 | $226.69 Million | $-40.63 Million | -0.179x | -51.97% |
| 2018-12-31 | $136.67 Million | $-16.12 Million | -0.118x | -100.57% |
| 2017-12-31 | $245.87K | $5.11 Million | 20.796x | +2675.61% |
| 2016-12-31 | $24.03 Million | $-19.40 Million | -0.807x | -- |